Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
04 Jan - 19 Feb 1993
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP - Guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1993
Report date:
1993

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Version / remarks:
adopted February, 1987
Deviations:
no
GLP compliance:
yes
Type of study:
Buehler test

Test material

Constituent 1
Chemical structure
Reference substance name:
N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine
EC Number:
262-679-1
EC Name:
N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine
Cas Number:
61260-55-7
Molecular formula:
C24H50N4
IUPAC Name:
N1,N6-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine

In vivo test system

Test animals

Species:
guinea pig
Strain:
Dunkin-Hartley
Sex:
female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Fa. Winkelmann, 4799 Borchen
- Age at study initiation: adult animals
- Weight at study initiation: 358 - 362 g
- Diet (ad libitum): Ssniff G 4 - Alleindiät for guinea pigs, Firma Ssniff, Spezialfutter GmbH, 4770 Soest
- Water (ad libitum): tap water, Fa. Gelsenwasser, Wasserwerk, 4358 Haltern
- Acclimation period: at least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 ± 3
- Humidity (%): 30 - 70
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12 / 12

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
epicutaneous, occlusive
Vehicle:
petrolatum
Concentration / amount:
1.0% (Induction and Challenge), 10.0% (Preliminary and Induction))
Challengeopen allclose all
Route:
epicutaneous, occlusive
Vehicle:
petrolatum
Concentration / amount:
1.0% (Induction and Challenge), 10.0% (Preliminary and Induction))
No. of animals per dose:
Preliminary study: 4
Main study: 20
Control group for main study: 10
Details on study design:
RANGE FINDING TESTS:
In the preliminary test, a concentration of 10.0% of the test substance in vaseline had no primary irritant effect. Therefore, for the induction phases I, II and III, and for the challenge treatment, the 10.0% test substance concentration in vaseline was initially established. Since, after the first induction inthe main study, skin irritation occurred in eight of 20 test animals, for the following inductions and for the challenge treatment, the test substance concentration was decreased to 1.0%.

MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 3
- Exposure period: 6 hours
- Control group: 10 animals (Vehicle treated)
- Site: left flank
- Test groups: 20 animals
- Frequency of applications: single exposure (Induction 1 (day 0) and Inductions 2 (day 7) and 3 (day 14))
- Duration: 0-14 d
- Concentrations: Induction 1: 10.0% Induction 2 and 3: 1.0%

B. CHALLENGE EXPOSURE
- No. of exposures: single exposure
- Day of challenge: day 28
- Exposure period: 6 hours
- Test groups: 20 animals
- Control group: 10 animals (Test substance treated)
- Site: right flank
- Concentrations: 1.0%
- Evaluation (hr after challenge): 6, 24, 48, 72 hours
Challenge controls:
10 control animals were used in the main study.
Positive control substance(s):
not required

Results and discussion

In vivo (non-LLNA)

Resultsopen allclose all
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
1.0%
No. with + reactions:
0
Total no. in group:
20
Clinical observations:
20 animals displayed no effects
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 1.0%. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: 20 animals displayed no effects.
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
1.0%
No. with + reactions:
0
Total no. in group:
20
Clinical observations:
20 animals displayed no effects
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 1.0%. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: 20 animals displayed no effects.
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
1.0%
No. with + reactions:
0
Total no. in group:
20
Clinical observations:
20 animals displayed no effects
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 1.0%. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: 20 animals displayed no effects.
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
1.0%
No. with + reactions:
0
Total no. in group:
20
Clinical observations:
20 animals displayed no effects
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 1.0%. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: 20 animals displayed no effects.
Reading:
other: 3rd reading
Hours after challenge:
72
Group:
negative control
Dose level:
1.0%
No. with + reactions:
0
Total no. in group:
20
Clinical observations:
20 animals displayed no effects
Remarks on result:
other: Reading: other: 3rd reading. . Hours after challenge: 72.0. Group: negative control. Dose level: 1.0%. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: 20 animals displayed no effects.
Reading:
other: 3rd reading
Hours after challenge:
72
Group:
test chemical
Dose level:
1.0%
No. with + reactions:
0
Total no. in group:
20
Clinical observations:
20 animals displayed no effects
Remarks on result:
other: Reading: other: 3rd reading. . Hours after challenge: 72.0. Group: test group. Dose level: 1.0%. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: 20 animals displayed no effects.

Applicant's summary and conclusion

Interpretation of results:
not sensitising
Remarks:
Migrated information
Conclusions:
Under the experimental condition chosen, test substance was assessed as non-sensitising to the skin.